Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Medicure Inc

MCUJF
Current price
0.73 USD 0 USD (0.00%)
Last closed 0.6 EUR
Company
ISIN CA58469E4085
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange F
Capitalization 7 054 614 EUR
Yield for 12 month -36.27 %
1Y
3Y
5Y
10Y
15Y
MCUJF
21.11.2021 - 28.11.2021

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Address: 2-1250 Waverley Street, Winnipeg, MB, Canada, R3T 6C6

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+14 305 329 EUR

Last Year

+15 209 386 EUR

Current Quarter

+3 405 874 EUR

Last Quarter

+3 754 704 EUR

Current Year

+9 224 544 EUR

Last Year

+10 600 081 EUR

Current Quarter

+1 946 590 EUR

Last Quarter

+2 569 737 EUR

Key Figures MCUJF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -884 137 EUR
Operating Margin TTM -21.65 %
PE Ratio
Return On Assets TTM -5.63 %
PEG Ratio
Return On Equity TTM -12.9 %
Wall Street Target Price
Revenue TTM 20 864 445 EUR
Book Value 1.87 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -13.8 %
Dividend Yield
Gross Profit TTM 12 670 974 EUR
Earnings per share -0.17 EUR
Diluted Eps TTM -0.17 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -82.8 %
Profit Margin -12.56 %

Dividend Analytics MCUJF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MCUJF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 02.11.2012
Dividend Date

Stock Valuation MCUJF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 12.1803
Enterprise Value Revenue 0.2483
Price Sales TTM 0.3381
Enterprise Value EBITDA 6.6635
Price Book MRQ 0.5181

Financials MCUJF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MCUJF

For 52 weeks

0.63 EUR 1.16 EUR
50 Day MA 0.69 EUR
Shares Short Prior Month
200 Day MA 0.74 EUR
Short Ratio
Shares Short
Short Percent